| Dr Stephen Michael Vindigni, MD, MPH | |
|
9701 Sw Barnes Rd Ste 300, Portland, OR 97225-6689 | |
| (503) 297-8081 | |
| (503) 292-6601 |
| Full Name | Dr Stephen Michael Vindigni |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 9701 Sw Barnes Rd Ste 300, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548559552 | NPI | - | NPPES |
| 500805026 | Medicaid | OR | |
| 2019001 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD209279 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Clinic Pc | 2860390408 | 319 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
"[A]s the worst drought in 60 years again devastates the Horn of Africa, throwing as many as 12 million into desperate hunger … there are hopeful signs that today's drought need not result in the tens of thousands of deaths that we saw in earlier decades," World Food Programme Executive Director Josette Sheeran writes in the Reuters blog "The Great Debate."
Hospitals, health plans and other organizations can ease their care management and patient-tracking workload with new tools and features available in CareWebQI((R)) Version 1.9 from Milliman Care Guidelines.
Oncolytics Biotech Inc. today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN® versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
› Verified 1 days ago
| Entity Name | Oregon Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265417174 PECOS PAC ID: 2860390408 Enrollment ID: O20031222000096 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
"[A]s the worst drought in 60 years again devastates the Horn of Africa, throwing as many as 12 million into desperate hunger … there are hopeful signs that today's drought need not result in the tens of thousands of deaths that we saw in earlier decades," World Food Programme Executive Director Josette Sheeran writes in the Reuters blog "The Great Debate."
Hospitals, health plans and other organizations can ease their care management and patient-tracking workload with new tools and features available in CareWebQI((R)) Version 1.9 from Milliman Care Guidelines.
Oncolytics Biotech Inc. today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN® versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Michael Vindigni, MD, MPH 541 Ne 20th Ave Ste 225, Portland, OR 97232-2895 Ph: (503) 963-2801 | Dr Stephen Michael Vindigni, MD, MPH 9701 Sw Barnes Rd Ste 300, Portland, OR 97225-6689 Ph: (503) 297-8081 |
News Archive
Two leading insurers reported second-quarter earnings with rising profits this week.
"[A]s the worst drought in 60 years again devastates the Horn of Africa, throwing as many as 12 million into desperate hunger … there are hopeful signs that today's drought need not result in the tens of thousands of deaths that we saw in earlier decades," World Food Programme Executive Director Josette Sheeran writes in the Reuters blog "The Great Debate."
Hospitals, health plans and other organizations can ease their care management and patient-tracking workload with new tools and features available in CareWebQI((R)) Version 1.9 from Milliman Care Guidelines.
Oncolytics Biotech Inc. today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN® versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).
› Verified 1 days ago
Salona Shrestha, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |